BioPharmSignal logoBioPharmSignal

Biotech News

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Pulse Biosciences (PLSE)Pulse BiosciencesConference / presentation

HAYWARD, Calif. --(BUSINESS WIRE)--May 27, 2026-- Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced plans to participate in the upcoming Goldman Sachs 47 th Annual Global Healthcare Conference

Related news

PLSEPulse Biosciences2026-07-30 20:05 EST

Pulse Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference

CVRXCVRx2026-05-27 20:30 EST

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

ANGOAngioDynamics2026-05-27 12:30 EST

AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

ATRCAtriCure2026-05-27 12:00 EST

AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

IARTIntegra LifeSciences2026-06-02 11:30 EST

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

IARTIntegra LifeSciences2026-06-15 12:30 EST

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

TCMDTactile Systems Technology, Inc.2026-05-20 20:05 EST

Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference

PLSEPulse Biosciences2026-08-06 20:05 EST

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

ICUSeaStar Medical2026-06-22 12:45 EST

SeaStar Medical to Present at Upcoming Investor Summit Conference

TMCITreace Medical Concepts2026-06-11 20:05 EST

Treace to Present at the Sidoti Small Cap Conference

View all latest news

Pulse Biosciences

Nanosecond Pulsed-Field Ablation Pulse Biosciences develops the nPulse platform, which delivers proprietary nanosecond pulsed-field energy to ablate targeted tissue. The technology is designed to create nonthermal cellular effects and is being evaluated in cardiac and soft-tissue applications. Cardiac Catheter System The nPulse Cardiac...

Recent company news

PLSEPulse Biosciences2026-08-06 20:05 EST

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

PLSEPulse Biosciences2026-07-30 20:05 EST

Pulse Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference

PLSEPulse Biosciences2026-07-29 11:00 EST

Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study

PLSEPulse Biosciences2026-07-21 20:05 EST

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026

PLSEPulse Biosciences2026-07-15 20:05 EST

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Stock data

Close
38.24 USD
Market cap
1.68B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States